Shared on 23 Aug 25
Fair value Decreased 5.13%US And Poland Facility Expansion Will Fuel Sustainable Demand
The downward revision in SP Group’s price target primarily reflects reduced consensus revenue growth forecasts, with fair value now set at DKK370. What's in the News SP Group lowered its 2025 earnings and revenue guidance, now projecting full-year revenue growth between -3% and +3% (previously +3% to +10%).
Shared on 01 May 25
Fair value Increased 4.51%Completion Of Atlanta Factory Will Expand Presence In North American Healthcare Market
Shared on 23 Apr 25
Fair value Increased 2.63%Completion Of Atlanta Factory Will Expand Presence In North American Healthcare Market
AnalystConsensusTarget has decreased revenue growth from 6.7% to 5.6%.
Shared on 17 Apr 25
Completion Of Atlanta Factory Will Expand Presence In North American Healthcare Market
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
Completion Of Atlanta Factory Will Expand Presence In North American Healthcare Market
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Increased 0.46%Completion Of Atlanta Factory Will Expand Presence In North American Healthcare Market
AnalystConsensusTarget has decreased shares outstanding growth rate from -0.0% to -0.0%.
Shared on 26 Mar 25
Fair value Decreased 5.70%Completion Of Atlanta Factory Will Expand Presence In North American Healthcare Market
AnalystConsensusTarget has decreased shares outstanding growth rate from -0.0% to -0.0%.
Shared on 19 Mar 25
Fair value Decreased 1.59%Completion Of Atlanta Factory Will Expand Presence In North American Healthcare Market
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 13 Mar 25